Contribution of endothelin receptors and cyclooxygenase-derivatives to the altered response of the rabbit renal artery to endothelin-1 in diabetes
-
Add time:07/30/2019 Source:sciencedirect.com
The influence of diabetes on regulatory mechanisms and specific receptors implicated in the response of isolated rabbit renal artery to endothelin-1 was examined. Endothelin-1 induced a concentration-dependent contraction that was less potent in arteries from diabetic rabbits than in arteries from control rabbits. Endothelium removal or NG-nitro-l-arginine (L-NOARG) enhanced contractions to endothelin-1 either in control and diabetic arteries. Indomethacin inhibited endothelin-1-induced response in control arteries, but enhanced it in diabetic arteries. In contrast to that observed in rubbed and in L-NOARG treated arteries, in the presence of indomethacin the contractile action of endothelin-1 was higher in diabetic arteries than in control arteries. Nimesulide enhanced endothelin-1 contractions both in control and diabetic arteries. Cyclo-(d-Asp-Pro-d-Val-Leu-d-Trp) (BQ-123, endothelin ETA receptor antagonist), attenuated endothelin-1 vasoconstriction in control rabbits, while vasoconstriction resulted increased in diabetic rabbits. 2,6-Dimethylpiperidinecarbonyl-γ-Methyl-Leu-Nin-(Methoxycarbonyl)-d-Trp-d-Nle (BQ-788, endothelin ETB receptor antagonist), enhanced the contractile response in control rabbit arteries without modifying this response in diabetic rabbits. In summary, diabetes decreases the sensitivity of the rabbit renal artery to endothelin-1 by decreasing the ratio between vasoconstrictor and vasodilator prostanoids released after activation of endothelin ETA receptors.
We also recommend Trading Suppliers and Manufacturers of endothelin, Nle(7)- (cas 134699-39-1). Pls Click Website Link as below: cas 134699-39-1 suppliers
Prev:Heteroannelated (+)-muricatacin (cas 134698-86-5) mimics: synthesis, antiproliferative properties and structure–activity relationships
Next:Isomorphous replacement of cystine with selenocystine in endothelin: oxidative refolding, biological and conformational properties of [Sec3,Sec11,Nle7]-endothelin-11) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Receptor and mechanism that mediate endothelin- and big endothelin-1-induced phosphoinositide hydrolysis in the rat spinal cord08/08/2019
- Pharmacological characterization of TA-0201, an endothelin receptor antagonist, with recombinant and human prostate endothelin receptors08/07/2019
- Binding of a new bioactive 31-amino-acid endothelin-1 to an endothelin ETB or ETB-like receptor in porcine lungs08/06/2019
- Enhanced response of pig coronary arteries to endothelin-1 after ischemia–reperfusion. Role of endothelin receptors, nitric oxide and prostanoids08/05/2019
- Depressor responses to endothelin-1 into the superior colliculus of rats: predominant role of endothelin ETB receptors08/04/2019
- Intrathecal endothelin-1 has antinociceptive effects in rat model of postoperative pain08/03/2019
- B103 neuroblastoma cells predominantly express endothelin ETB receptor; effects of extracellular Ca2+ influx on endothelin-1-induced mitogenesis08/02/2019
- Different role of endothelin ETA and ETB receptors and endothelial modulators in diabetes-induced hyperreactivity of the rabbit carotid artery to endothelin-108/01/2019
- Isomorphous replacement of cystine with selenocystine in endothelin: oxidative refolding, biological and conformational properties of [Sec3,Sec11,Nle7]-endothelin-1107/31/2019
-
Health and Chemical more >
-
Related Products


